History
the way SPMED walked
06 Trademark registration (MyDrugGene PDSS, MyDate SPMED)
11 First recombinant proteinase export to Northern Europe (Finland ADMESCOPE)
04 Mid-Market: Export vouchers and 1,000+ promising projects for global powerhouses
03 7th Annual General Meeting of Shareholders
01 SPMEDTM Genotyping Kit (CYP2D6) – participate the 4th Fast Track II business of 2022
12 SPMEDTM Genotyping Kit (CYP2D6) – be selected the 4th Fast Track II business of 2022.
11 Be selected “the 200 Baby Unicorns business”
07 Launched mobile application “My Data SPMED” First export of Pharmacogenomics kit to Europe
06 Selected as an influential service provider by Busan Metropolitan City (in the medical field)
02Establishment of Gwanggyo Strategic Business office
01 Acquisition of A rank quality evaluation for genetic testing institutions – 3 consecutive years Expanded export of human recombinant enzymes to China (3 times in January, June, July)
12 Purchase of land for the construction of a new office building (Busan Eco Delta City, relocation of headquarter in 2024) Moved to Urban Tech House in Smart Village of Busan Eco Delta City Awarded as the Life Care strategic industry leading company in Busan Metropolitan City
09 Trademark registration (SPMED PGx, PGxSPMED, PDSS) Acquired the certificate of start-up business from the Ministry of SMEs and Startups
07 Awarded Series A investment (Korea Investment Partners Co., Ltd, IMM Investment, Time Folio) Establishment of Seoul office
04 Medical device quality management system ISO13485:2016 certification
03 Patent Registration of Multiplex drug gene analysis kit for predicting drug side effects on chronic diseases and cancer related multi-prescription drugs and personalized drug treatmen Patent Registration of My Prescription Service Terminal, System and Method
01 Acquisition of “A” rank quality evaluation for genetic testing institutions
11SPMED™ Genotyping Kit: CYP2D6 Genotyping Kit CE-IVDD Certification
07 Signing a business agreement with Illumina for joint research and mutual cooperation Patent Registration of METHOD FOR QUICK-DETECTING HLA ALLELES ASSOCIATED WITH ADVERSE DRUG REACTION USING tSNP
06The Korea Health Industry Promotion Agency (KIHIC) Selection of 2020 Startup and Leap Package Support Project
05Selected as Busan Metropolitan City's leading start-up company (Platinum) in 2020
04SPMED™ Genotyping Kit:CYP2D6 Genotyping Test Kit Permission for Medical Device Manufacturing(Permit No:No.20-297)
04Patent registration of high speed detection kit for human cytochrome P450 2D6 mutant gene
03 Awarded Pre-A investment (Korea Investment Partners Co., Ltd) Alliance of Pharmacogenomic Service Marketing Business
02SPMED PGx Solution (Genotyping Kit Software) Development Completed
01 Inauguration of Jae-Gook Shin as CEO Patent Registration of UDP-GLUCURONOSYLTRANSFERASE SINGLE NUCLEOTIDE POLYMORPHISM MARKERS AND USE THEREOF Signed contract to supply recombinant human metabolizing enzyme in China
12Conclusion of MOU for mutual cooperation with ChemOn Inc.
08Patent Registration of METHOD FOR MANUFACTURING RECOMBINANT PROTEIN OF DRUG METABOLIZING ENZYME GENE USING BACULOVIRUS SYSTEM
04 Conclusion of agreement on hospital designations for pharmacogenomic testing (Isam Hospital and Busan Adventist Hospital)
03 Registration with the Association of Genomic Companies Inauguration of Hwang Sang-jun as CEO
12 Registration with the Bio Association
09 Selected to implement innovative R&D project as part of the Ministry of SMEs and Startups’ Technological Development Program for Startup Growth
08 Selected for the Ministry of SMEs and Startups’ Technological Development Program for the Promotion of Regional Specialized Industries Selected for Didimdol Startup Project as part of the Ministry of SMEs and Startups’ Technological Development Program for Startup Growth
06Selected as Representative Startup of Busan in 2018 (Bright Club)
05Selected for Knowledge Service Idea Commercialization Support Program of the Busan Economic Promotion Agency
01Confirmation as Venture Company
12Completion of KGMP certification process for medical devices
10Notification of installation and operation of LMO research facility
07Approval of R&D Center (by the Ministry of Science, ICT and Future Planning)
06Relocation of headquarters
05Selected for Open Lab Operation Program of the Busan Innovation Institute of Industry, Science & Technology Planning (BISTEP)
10 Selected for Women’s Participation Promotion Project by the Small and Medium Business Administration Selected for industry-university-research technological development project of the Small and Medium Business Administration
07 Notification of status as genetic testing agency for the Centers for Disease Control and Prevention Korea Selected as 7th Busan Startup Support Program of the Busan Economic Promotion Agency Conclusion of industry-university cooperation agreement with Inje University
06 Conclusion of industry-university cooperation agreement with Inje University Pharmacogenomic Research Center Establishment of affiliated R&D center of SPMED Confirmation as Woman Biz by the Korean Women Entrepreneurs Association
04 Establishment of SPMED Co., Ltd. Business Registration No. 662-81-00277